ICD-10 Coding for Elevated Hemoglobin(D75.1, D75.1B, D75.1S)
Learn about ICD-10 coding for elevated hemoglobin, including polycythemia vera and secondary polycythemia. Understand documentation requirements and coding pitfalls.
Complete code families applicable to Elevated Hemoglobin
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D45 | Polycythemia vera | Use when polycythemia vera is confirmed by clinical and laboratory findings. |
|
| D75.1 | Secondary polycythemia | Use when elevated hemoglobin is secondary to another condition. |
|
| R71.8 | Other specified abnormal findings of blood chemistry | Use when elevated hemoglobin is noted but the etiology is not yet determined. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutElevated Hemoglobin
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Elevated Hemoglobin.
Failing to document the cause of secondary polycythemia.
Impact
Clinical: Misrepresentation of patient's condition., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Always document the underlying cause of secondary polycythemia., Use appropriate sequencing of codes.
Coding elevated hemoglobin as D45 without JAK2 confirmation.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure JAK2 mutation is documented before using D45.
JAK2 mutation documentation
Impact
Lack of documentation for JAK2 mutation in polycythemia vera cases.
Mitigation
Ensure all polycythemia vera diagnoses include JAK2 test results.